These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33718181)

  • 1. Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia.
    Kulkarni U; Mathews V
    Front Oncol; 2021; 11():621566. PubMed ID: 33718181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis].
    Xu SN; Chen JP; Liu JP; Xia Y
    Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1024-34. PubMed ID: 19912733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-related myeloid neoplasms following curative treatment of acute promyelocytic leukemia: incidence, correlation with therapeutic regimen, and future directions.
    Menon A; Sukhanova M; Gao J; Wolniak K; Fu L; Chen YH; Chen QC; Tariq H
    J Hematop; 2024 Dec; 17(4):201-208. PubMed ID: 39254828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK Experience of an Alternative ATO Dosing Regimen in APL.
    Russell N; Dillon R
    Front Oncol; 2020; 10():594129. PubMed ID: 33262951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
    Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
    Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of arsenic trioxide in acute promyelocytic leukemia.
    Iland HJ; Seymour JF
    Curr Treat Options Oncol; 2013 Jun; 14(2):170-84. PubMed ID: 23322117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience.
    Autore F; Chiusolo P; Sorà F; Giammarco S; Laurenti L; Innocenti I; Metafuni E; Piccirillo N; Pagano L; Sica S
    Front Oncol; 2021; 11():614721. PubMed ID: 34336637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.
    Ghavamzadeh A; Jalili M; Rostami S; Yaghmaie M; Aliabadi LS; Mousavi SA; Vaezi M; Fumani HK; Jahani M; Alimoghaddam K
    Leuk Res; 2018 Mar; 66():85-88. PubMed ID: 29407588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies in acute promyelocytic leukemia: moving to an entirely oral, chemotherapy-free upfront management approach.
    Zeidan AM; Gore SD
    Clin Cancer Res; 2014 Oct; 20(19):4985-93. PubMed ID: 25274377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapies for newly diagnosed acute promyelocytic leukemia].
    Yokoyama Y
    Rinsho Ketsueki; 2020; 61(9):1166-1173. PubMed ID: 33162512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia.
    Thomas X
    Oncol Ther; 2019 Jun; 7(1):33-65. PubMed ID: 32700196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.
    Kutny MA; Alonzo TA; Abla O; Rajpurkar M; Gerbing RB; Wang YC; Hirsch BA; Raimondi S; Kahwash S; Hardy KK; Hardy S; Meshinchi S; Gamis AS; Kolb EA; Feusner JH; Gregory J
    JAMA Oncol; 2022 Jan; 8(1):79-87. PubMed ID: 34762093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the diagnosis and management of childhood acute promyelocytic leukemia.
    Yoo ES
    Korean J Pediatr; 2011 Mar; 54(3):95-105. PubMed ID: 21738538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
    Zhang L; Zou Y; Chen Y; Guo Y; Yang W; Chen X; Wang S; Liu X; Ruan M; Zhang J; Liu T; Liu F; Qi B; An W; Ren Y; Chang L; Zhu X
    BMC Cancer; 2018 Apr; 18(1):374. PubMed ID: 29615003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).
    Chen L; Zhu HM; Li Y; Liu QF; Hu Y; Zhou JF; Jin J; Hu JD; Liu T; Wu DP; Chen JP; Lai YR; Wang JX; Li J; Li JY; Du X; Wang X; Yang MZ; Yan JS; Ouyang GF; Liu L; Hou M; Huang XJ; Yan XJ; Xu D; Li WM; Li DJ; Lou YJ; Wu ZJ; Niu T; Wang Y; Li XY; You JH; Zhao HJ; Chen Y; Shen Y; Chen QS; Chen Y; Li J; Wang BS; Zhao WL; Mi JQ; Wang KK; Hu J; Chen Z; Chen SJ; Li JM
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33495363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian network meta-analysis comparing five contemporary treatment strategies for newly diagnosed acute promyelocytic leukaemia.
    Wu F; Wu D; Ren Y; Duan C; Chen S; Xu A
    Oncotarget; 2016 Jul; 7(30):47319-47331. PubMed ID: 27322078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome.
    LaBella D; Regan S; Konig H; Egan DN; Bailey NA; Mawad R; Gilbert M; Pagel JM; Pu JJ
    Front Oncol; 2022; 12():911745. PubMed ID: 35992790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.